Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Barlow

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Plos One|November 7, 2009
Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycleRachel J Skilton, Lesley T Cutcliffen, David Barlow, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 13, 2005
Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populationsTasneem Asghar, Shigeki Yoshida, Satoshi Nakago, et al.
Biochimica Et Biophysica Acta|November 24, 2015
The influence of rough lipopolysaccharide structure on molecular interactions with mammalian antimicrobial peptidesGianluca Bello, Alice Bodin, M Jayne Lawrence, et al.
Human Reproduction (Oxford, England)|August 21, 2004
The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese populationTasneem Asghar, Shigeki Yoshida, Stephen Kennedy, et al.
Maturitas|June 30, 2004
Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapySven O Skouby, David Barlow, Göran Samsioe, et al.
Scientific Reports|March 7, 2020
Revealing the Hidden Details of Nanostructure in a Pharmaceutical CreamDelaram Ahmadi, Najet Mahmoudi, Peixun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trialCatherine Van Poznak, Rosemary A Hannon, John R Mackey, et al.
The American Journal of Psychiatry|February 3, 2007
A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapySue M Marcus, Jack Gorman, M Katherine Shear, et al.
Maturitas|May 11, 2005
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapySven O Skouby, Farook Al-Azzawi, David Barlow, et al.
Circulation. Arrhythmia and Electrophysiology|July 23, 2013
Myocardial infarction and atrial fibrillation: importance of atrial ischemiaMuayad Alasady, Nicholas J Shipp, Anthony G Brooks, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Plos One|November 7, 2009
Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycleRachel J Skilton, Lesley T Cutcliffen, David Barlow, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 13, 2005
Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populationsTasneem Asghar, Shigeki Yoshida, Satoshi Nakago, et al.
Biochimica Et Biophysica Acta|November 24, 2015
The influence of rough lipopolysaccharide structure on molecular interactions with mammalian antimicrobial peptidesGianluca Bello, Alice Bodin, M Jayne Lawrence, et al.
Human Reproduction (Oxford, England)|August 21, 2004
The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese populationTasneem Asghar, Shigeki Yoshida, Stephen Kennedy, et al.
Maturitas|June 30, 2004
Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapySven O Skouby, David Barlow, Göran Samsioe, et al.
Scientific Reports|March 7, 2020
Revealing the Hidden Details of Nanostructure in a Pharmaceutical CreamDelaram Ahmadi, Najet Mahmoudi, Peixun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trialCatherine Van Poznak, Rosemary A Hannon, John R Mackey, et al.
The American Journal of Psychiatry|February 3, 2007
A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapySue M Marcus, Jack Gorman, M Katherine Shear, et al.
Maturitas|May 11, 2005
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapySven O Skouby, Farook Al-Azzawi, David Barlow, et al.
Circulation. Arrhythmia and Electrophysiology|July 23, 2013
Myocardial infarction and atrial fibrillation: importance of atrial ischemiaMuayad Alasady, Nicholas J Shipp, Anthony G Brooks, et al.
Pageof 6